Skip Navigation

St. Luke's Cancer Institute

Location

St. Luke's Cancer Institute
100 E Idaho
Boise, ID 83712
Direct phone: (208) 381-1679

Total transplants by cell source

From January 1, 2019 to December 31st, 2020
  • Marrow: 0
  • PBSC: 23
  • Cord Blood: 0
  • Autologous (PBSC or Marrow): 56
Performs adult; pediatric transplants

Overview

The St. Luke's Cancer Institute – Center for Blood Cancer Therapy offers comprehensive care and cellular therapy for patients with leukemia, lymphoma, multiple myeloma, myelodysplastic disorders, and other blood cancers. We're proud to be Idaho's only blood and marrow transplant program, offering autologous and allogeneic bone marrow/stem cell transplants at St. Luke’s Boise. Our dedicated team focuses on your quality of life while providing novel therapies, access to clinical trials, and supportive care, close to home.

This center has been performing allogeneic transplants since 2018 and has been an NMDP/Be The Match transplant center since May 2020.

Attending physicians

Adult - William Kreisle, Finn Petersen, Travis Williams

Transplants performed

Marrow/PBSC only

Cord blood transplants performed on

Not performed

Other programs and services

Our program offers full support from an interdisciplinary team specialized in the care of patient under going transplant. This team includes providers, social workers, patient financial advocates, pharmacists, and nurse navigators to help guide patients through the transplant process. Local discounted housing may be available in coordination with our social work team.

About the center

Overview

The St. Luke's Cancer Institute – Center for Blood Cancer Therapy offers comprehensive care and cellular therapy for patients with leukemia, lymphoma, multiple myeloma, myelodysplastic disorders, and other blood cancers. We're proud to be Idaho's only blood and marrow transplant program, offering autologous and allogeneic bone marrow/stem cell transplants at St. Luke’s Boise. Our dedicated team focuses on your quality of life while providing novel therapies, access to clinical trials, and supportive care, close to home.

This center has been performing allogeneic transplants since 2018 and has been an NMDP/Be The Match transplant center since May 2020.

Attending physicians

Adult - William Kreisle, Finn Petersen, Travis Williams

Transplants performed

Marrow/PBSC only

Cord blood transplants performed on

Not performed

Other programs and services

Our program offers full support from an interdisciplinary team specialized in the care of patient under going transplant. This team includes providers, social workers, patient financial advocates, pharmacists, and nurse navigators to help guide patients through the transplant process. Local discounted housing may be available in coordination with our social work team.

Overall center survival


Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

  1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2017, 2018, 2019, and
  2. Who had their transplant at a U.S. transplant center, and
  3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 20 patients.

The actual 1-year survival of these patients is 90.0%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 55.2% and 92.0%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

Number of adult transplants

Total adult transplants


70

Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 0 16 0 16
Unrelated donor 0 7 0 7
Total allogeneic 0 23 0 23
Autologous
Both marrow & PBSC
47
-- 47
Total combined
70 0 70

Number of pediatric transplants

Total pediatric transplants


9

Transplants reported (From January 1, 2019 to December 31st, 2020 as reported by the centers)

Marrow PBSC Cord blood Total
Allogeneic
Related donor 0 0 0 0
Unrelated donor 0 0 0 0
Total allogeneic 0 0 0 0
Autologous
Both marrow & PBSC
9
-- 9
Total combined
9 0 9

Transplants by disease

All diseases

Number of transplants by age reported from January 1, 2019 to December 31st, 2020 (includes marrow, PBSC and cord blood)

0-18 19-44 45-64 65+ Total
Related 0 4 5 7 16
Unrelated 0 1 5 0 6
Autologous 9 4 26 17 56
Total 9 9 36 24 78

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants for this disease can be found:

Additional information

Transplant center resources

Transplant center coordinator:
Kelly Hofstra
(208) 381-1679
Email: hofstrak@slhs.org

Financial representative:
Rifeta Kajdic
(208) 381-9542
Email: kajdicr@slhs.org

Be The Match patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743

Outside the United States: 1 (763) 406-3410.
(Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

Survivorship program


No survivorship program information is available. Contact the center for information about post-transplant care.